Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation

Inoue Yoshitaka; Endo Shinya; Matsuno Naofumi; Kikukawa Yoshitaka; Shichijo Takafumi; Koga Kenichi; Takaki Ayumi; Iwanaga Kouta; Nishimura Nao; Fuji Shigeo; Fukuda Takahiro; Nosaka Kisato; Matsuoka Masao

首页> 外文期刊>Bone marrow transplantation >Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation

【24h】

Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation

机译：同种异体造血细胞移植后，Mogamulizumab用于复发ATL的安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2019年第2期|共5页
作者
Inoue Yoshitaka; Endo Shinya; Matsuno Naofumi; Kikukawa Yoshitaka; Shichijo Takafumi; Koga Kenichi; Takaki Ayumi; Iwanaga Kouta; Nishimura Nao; Fuji Shigeo; Fukuda Takahiro; Nosaka Kisato; Matsuoka Masao;
展开▼
作者单位

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Natl Canc Ctr Hematopoiet Stem Cell Transplantat Div Tokyo Japan;

Natl Canc Ctr Hematopoiet Stem Cell Transplantat Div Tokyo Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

Kumamoto Univ Hosp Dept Hematol Kumamoto Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation [J] . Inoue Yoshitaka, Endo Shinya, Matsuno Naofumi, Bone marrow transplantation . 2019,第2期

机译：同种异体造血细胞移植后，Mogamulizumab用于复发ATL的安全性
2. Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality [J] . Inoue Yoshitaka, Fuji Shigeo, Tanosaki Ryuji, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：在针对ATLL的异基因造血细胞移植之前施用Mogamulizumab可能会增加急性Gvhd和非复发性死亡率的风险
3. Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Schubert Maria-Luisa, Dietrich Sascha, Stilgenbauer Stephan, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2020,第9期

机译：同种异体造血干细胞移植后B细胞淋巴瘤复发的CD19嵌合抗原受体T细胞治疗的可行性和安全性
4. Allogeneic Hematopoietic Stem Cell Transplantation For Atl [C] . Mari Kannnagi, Masao Matsuoka, Takashi Uchiyama, Japanese Cancer Association . 2003

机译：ATL的同种异体造血干细胞移植
5. Folate status and risk of relapse following allogeneic hematopoietic cell transplant for chronic myelogenous leukemia. [D] . Robien, Kimberly Ziemer. 2003

机译：异基因造血细胞移植治疗慢性粒细胞白血病后的叶酸状况和复发风险。
6. Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma [O] . Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani, -1

机译：PD-1阻断后异基因造血干细胞移植治疗复发/难治性淋巴瘤的安全性和有效性
7. Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality [O] . Inoue Yoshitaka, Fuji Shigeo, Tanosaki Ryuji, 2015

机译：异基因造血细胞移植之前针对抗ATLL的Mogamulizumab给药可能会增加急性Gvhd和非复发性死亡率的风险

Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation

著录项

相似文献

相关主题

期刊订阅